Alexza Pharmaceuticals Inc.

CIK 1344413 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alexza Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Jan 16, 2018CT ORDER9999999997-18-000379
Jan 16, 2018CT ORDER9999999997-18-000378
Mar 31, 2017CT ORDER9999999997-17-005239
Mar 31, 2017CT ORDER9999999997-17-005238
Mar 31, 2017CT ORDER9999999997-17-005240
Jul 15, 201615-12G0001193125-16-649398
Jul 7, 2016EFFECT9999999995-16-005090
Jul 7, 2016EFFECT9999999995-16-005091
Jul 7, 2016EFFECT9999999995-16-005092
Jul 5, 2016S-8 POS0001193125-16-641594
Jul 5, 2016S-8 POS0001193125-16-641611
Jul 5, 2016S-8 POS0001193125-16-641627
Jul 5, 2016POS AM0001193125-16-641578
Jul 5, 2016S-8 POS0001193125-16-641670
Jul 5, 2016S-8 POS0001193125-16-641666
Jul 5, 2016S-8 POS0001193125-16-641607
Jul 5, 2016S-8 POS0001193125-16-641646
Jul 5, 2016POS AM0001193125-16-641584
Jul 5, 2016POS AM0001193125-16-641576
Jul 5, 2016S-8 POS0001193125-16-641652
Jul 5, 201625-NSE0001354457-16-000422
Jul 5, 2016S-8 POS0001193125-16-641634
Jul 5, 2016S-8 POS0001193125-16-641640
Jul 5, 2016S-8 POS0001193125-16-641662
Jul 5, 2016S-8 POS0001193125-16-641623